Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home    

Healthcare Market Research Reports

PRODUCT TITLE PUBLISHED
European Interventional Cardiology Devices European Interventional Cardiology Devices
The European Interventional Cardiology Devices Market was pegged at $3.9 billion in 2013 and expected to be $6.1 billion by 2018, growing at a CAGR of 9%. The European Interventional Cardiology Devices Marketby Geographies, Applications, Technologies, Products, Endusers, Companies and MacroIndicators. Deep dive analysis of the top players  of this market have been considered in this report.
Upcoming
Pulse Oximeters Pulse Oximeters
The Global Pulse Oximeters market has gained tremendous importance owing to the large patient pool for Obstructive Sleep Apnea (OSA). The market is clinched at $605.4 million in 2013 and is expected to reach a value of $1.3 billion in 2018, with a CAGR of 16.1% from 2013-2018. The market has been segmented on the basis of Products, Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the key players have been considered in this report.
Upcoming
Asian Interventional Cardiology Devices Asian Interventional Cardiology Devices
The total Asia Pacific Interventional Cardiology Devices Market is expected to grow at a fast pace. Increased number of procedures in India and China will drive the Market. The Interventional Cardiology Devices Market can be segmented by Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the major players of the market are considered in this report.
Upcoming
Polysomnography (PSG) Device Polysomnography (PSG) Device
The global PSG Devices market has gained tremendous importance owing to the large patient base of Obstructive Sleep Apnea (OSA). The market was valued at $2.2 billion in 2013 and is expected to reach a value of $4.4 billion in 2018, with a CAGR of 14.7% from 2013 to 2018. The market has been segmented on the basis of products, geographies, end users, companies, and macro indicators. A deep-dive analysis of the key players in the market has been provided in this report.
Upcoming
North American Clinical Chemistry North American Clinical Chemistry
The North American clinical chemistry market was estimated at $3,852.7 million in 2013 and is expected to reach $5,370.5 million by 2019, at a CAGR of 7.2% from 2013 to 2018. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report.
Upcoming
Global Spirometers Market Global Spirometers Market
The “Global Spirometer Market”, mainly driven by increase of respiratory diseases, was pegged at $ 397 million in 2012 and expected to be $ 661 billion by 2020, growing at a CAGR of 6.5%. The market has 2 segments such as Table-top and Handheld monitors. The major player in the market are CareFusion (U.S.), Cosmed (Italy), Philips Healthcare (Netherlands), Micro Direct (U.K.), Schiller (Switzerland), Welch Allyn (U.S.), and SDI Diagnostics (U.S.).
Upcoming
Oxygen Delivery Systems Oxygen Delivery Systems
The global oxygen delivery systems market forms an integral part of the healthcare industry. The market was valued at $548 million in 2013 and is expected to reach a value of $1.6 billion in 2018, at a CAGR of 16.2% from 2013 to 2018. The market has been segmented on the basis of products, geographies, end users, companies, and macro indicators. A deep-dive analysis of the key players in the market has been provided in this report.
Upcoming
North American Cardiac Monitoring Devices North American Cardiac Monitoring Devices
North America is the world leader for the Cardiac Monitoring Devices Market.The Cardiac Monitoring Devices Market can be segmented on the basis of devices, geography, Companies and Macroindicator.Deep dive analysis of the top players of this market have been considered in this report.
Upcoming
European Cardiac Monitoring Devices European Cardiac Monitoring Devices
Europe has the second largest share in the Global Cardiac Monitoring Devices Market.The Cardiac Monitoring Devices Market can be segmented on the basis of devices, geography, Companies and Macroindicator.Deep dive analysis of the top players of this market have been considered in this report.
Upcoming
Asian Cardiac Monitoring Devices Asian Cardiac Monitoring Devices
Market Volume growth is significantly higher in Asia (India, China, Japan) because of rising incidence of CVD and increased purchasing power of patients in India and China will drive this market.The Cardiac Monitoring Devices Market can be segmented on the basis of devices, geography, Companies and Macroindicator.Deep dive analysis of the top players of this market have been considered in this report.
Upcoming
Positive Airway Pressure (PAP) Positive Airway Pressure (PAP)
The global Positive Airway Pressure (PAP) device market has gained tremendous importance owing to the large patient base of Obstructive Sleep Apnea (OSA). The market was valued at $4.7 billion in 2013 and is expected to reach a value of $10.4 billion in 2018, with a CAGR of 17.3% from 2013 to 2018. The market has been segmented on the basis of products, geographies, end users, companies, and macro indicators. A deep-dive analysis of the key players has been provided in this report.      
Upcoming
Anesthesia Monitoring Devices Anesthesia Monitoring Devices
The “Global Anesthesia monitoring devices Market”, mainly driven by increase in the number of surgeries, was pegged at $ 414 million in 2012 and expected to be $ 618 million by 2020, growing at a CAGR of 6.8%. The report analyzes the market of monitors by 2 segments such as Portable and Stationary. The main companies operating in the market and extensively covered in this report are GE Healthcare, Philips, Mindray, Covidien, Drager, etc.
Upcoming
Facial Interfaces Facial Interfaces
The Global Facial Interface market constitutes a growing market and a prime part of the Healthcare industry. Masks forms the major contributor in this market and is growing at a CAGR of 17.2% from 2013-2018. The market has been segmented on the basis of Products, Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the key players have been considered in this report.
Upcoming
Americas Electrical Ablation Americas Electrical Ablation
The American Electrical Ablation Market was pegged at $387 million in 2013 and expected to be $480 million by 2018,. In electrical ablation market, electrical ablators accounted for a share of 90.4% in 2011. The main companies operating in electrical ablation market are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific (U.S), Angiodynamics (U.S), and Covidien (Ireland).
Upcoming
Asia-Pacific Electrical Ablation Asia-Pacific Electrical Ablation
The Asia-Pacific electrical ablation market was valued at $159.0 million in 2013 and is expected to reach $236.0 million by 2018. In the electrical ablation market, electrical ablators accounted for a share of 90.4% in 2011. The main companies operating in Asia-Pacific Electrical Ablation market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland).
Upcoming
European Electrical Ablation European Electrical Ablation
The European electrical ablation market was valued at $189.0 million in 2013 and is expected to reach $228.0 million by 2018. In the European electrical ablation market, electrical ablators accounted for a share of 90.4% in 2011. The main companies operating in this market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland).
Upcoming
Americas Hydrothermal Ablation Americas Hydrothermal Ablation
The American Hydrothermal Ablation Market, mainly driven by growing aging population, with increasing incidence, and prevalence of chronic diseases such as cancer and cardiovascular disorders, rapid acceptance of new medical technology, and well covered reimbursement system. The main companies operating in hydrothermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others
Upcoming
Asia-Pacific Hydrothermal Ablation Asia-Pacific Hydrothermal Ablation
The Asia-Pacific Hydrothermal Ablation Market, mainly driven by increasing aging population with higher risk of chronic diseases and increasing age related chronic diseases. The main companies operating in Hydrothermal Ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others.
Upcoming
European Hydrothermal Ablation European Hydrothermal Ablation
The European Hydrothermal Ablation Market, mainly driven by increasing aging population with higher risk of chronic diseases and increasing age related chronic diseases. The main companies operating in Hydrothermal Ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others.
Upcoming
North American Cardiac Rhythm Management Devices North American Cardiac Rhythm Management Devices
The North American Cardiac Rhythm Management Devices Market, mainly driven by Increasing Incidence of Lifestyle Diseases &Cardiovascular Diseases, was pegged at $ 4.25 billion in 2012 and expected to be $ 8.04 billion by 2018.The market is segmented by Type of devices, Geography, Companies and Macroindicator. Deep dive analysis of the major players of this market are considered in this report.
Upcoming
2987 reports | Show
Connect With Us
US/CAN : +1-888-502-0539